2023 was a troublesome year for that biopharma industry, with numerous corporations downsizing and restructuring their workforces to remain afloat. You'll find signs of recovery, as mergers and acquisitions picked up over the pharmaceutical and lifetime sciences field in the latter Portion of 2023 and also have continued their upswing https://sites.google.com/view/bio-sites/blog